Even short-term use of popular acid-reducing heartburn drugs may raise the risk of hip fractures, U.S. researchers said on Monday. The increased risks appeared two years after patients started taking proton pump inhibitors such as Takeda Pharmaceutical Co’s Prevacid and histamine-2 receptor antagonists, or H2RAs, such as GlaxoSmithKline’s Zantac, researchers …
Read More »